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Background:
Traditionally, cases of severe combined immunodeficiency (SCID) are classified immunophenotypically
based on the lymphocyte subsets affected. More recently, there has been an increasing effort to
classify SCID by its genetic etiology as genotype influences treatment options and predicts prognosis.
However, in approximately 10-15% of SCID cases no genetic defect is identified.
Objectives/Goal:
We report two challenging cases of SCID with novel findings without identifiable genetic defects.
Methods/Design:
Case 1: An intrauterine growth restricted (IUGR), 34-week male infant presented with multiple
congenital anomalies (severe micrognathia requiring tracheostomy, cleft palate, agenesis of the corpus
callosum, sensorineural hearing loss, intestinal malrotation, nephrotic syndrome, pulmonary valve
stenosis and skeletal dysplasia). He was severely lymphopenic, and immune workup led to a phenotypic
diagnosis of T-B+NK+ SCID. He underwent a matched-sibling donor bone marrow transplant without
conditioning which led to donor T-cell engraftment. At 6 months of life, he presented with respiratory
failure due to staphylococcal tracheitis and died. Case 2: A term female IUGR infant presented at birth
with thrombocytopenia and severe lymphopenia. Immune workup led to a phenotypic diagnosis of
leaky T-B-NK+ SCID. She developed progressive hypoxic respiratory failure secondary to pulmonary

arterial hypertension (PAH) and required cannulation to extracorporeal membrane oxygenation
(ECMO). After ECMO decannulation, she died at 5 weeks of age from refractory PAH.
Results:
On exome sequencing, no reportable variants were identified in genes associated with SCID in either
case. In Case 1, exome sequencing identified 10 variants of unknown significance (VUS) (Table 1), one of
which, a hemizygous variant in SEPT6, c.44G>A (p.Arg15Gln), is particularly intriguing as this gene is
involved in neural tube development and lymphocyte migration. In case 2, exome sequencing identified
3 VUS (Table 1), one of which, a heterozygous variant in PSMB8, c.265G>T (p.Asp89Tyr), is of interest as
it was found to be a de novo mutation in a highly evolutionarily conserved amino acid residue
and was located within a gene involved in immunoproteasome formation.
Conclusions:
Despite advancements in the classification of SCID through identification of genetic defects, these cases
with non-diagnostic genetic work up highlight the limitation of presently available clinical genomic
testing.

